ASSET | DATE | % RETURN |
---|---|---|
Applied Opt (AAOI) | 6/1/2023 - 12/31/2023 | 782.19% |
Gyre Therapeutics (GYRE) | 6/1/2023 - 12/31/2023 | 613.61% |
Spyre Therapeutics (SYRE) | 6/1/2023 - 12/31/2023 | 562.15% |
MoneyLion (ML) | 6/1/2023 - 12/31/2023 | 467.33% |
ASP Isotopes Inc Common Stock (ASPI) | 6/1/2023 - 12/31/2023 | 466.46% |
Eyepoint Pharmaceuticals (EYPT) | 6/1/2023 - 12/31/2023 | 281.35% |
Alpha Technology Group Limited Ordinary Shares (ATGL) | 6/1/2023 - 12/31/2023 | 217.5% |
Pharvaris (PHVS) | 6/1/2023 - 12/31/2023 | 209.94% |
Ramaco Resources (METC) | 6/1/2023 - 12/31/2023 | 192.1% |
Altimmune (ALT) | 6/1/2023 - 12/31/2023 | 177.09% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 6/1/2023 - 12/31/2023 | 174.7% |
Olema Pharmaceuticals (OLMA) | 6/1/2023 - 12/31/2023 | 170.85% |
Blend Labs (BLND) | 6/1/2023 - 12/31/2023 | 160.2% |
Torrid (CURV) | 6/1/2023 - 12/31/2023 | 154.19% |
Bitfarms (BITF) | 6/1/2023 - 12/31/2023 | 153.04% |
Alpha Metallurgical Resources (AMR) | 6/1/2023 - 12/31/2023 | 152.9% |
CVRx (CVRX) | 6/1/2023 - 12/31/2023 | 150.32% |
First Foundation (FFWM) | 6/1/2023 - 12/31/2023 | 148.73% |
OppFi (OPFI) | 6/1/2023 - 12/31/2023 | 147.35% |
Taysha Gene Therapies (TSHA) | 6/1/2023 - 12/31/2023 | 145.83% |
Customers Bancorp (CUBI) | 6/1/2023 - 12/31/2023 | 144.26% |
Groupon (GRPN) | 6/1/2023 - 12/31/2023 | 138.66% |
Aspen Aerogels (ASPN) | 6/1/2023 - 12/31/2023 | 138.37% |
American Superconductor (AMSC) | 6/1/2023 - 12/31/2023 | 137.53% |
Neuropace (NPCE) | 6/1/2023 - 12/31/2023 | 134.32% |